Aquestive Therapeutics, Inc. — Director's Dealing 2021

Jun 18, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2021-06-15

Reporting Person: TOTH A ERNEST JR (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-15	Stock Option (Right to Purchase)	$4.04	A	120000	Acquired	2031-06-15	Common Stock (120000)	Direct

Footnotes

F1: Grant to the Reporting Person of a stock option to purchase Common Stock of the Issuer under the Issuer's 2018 Equity Incentive Plan (the "Plan"). Said options vest over a three-year period, with 25% of such option vesting on each of the one-year and two-year anniversaries of the option vesting commencement date and the remaining 50% vesting on the third-year anniversary of the option vesting commencement date, provided that at the relevant vesting date, the Reporting Person's continuous service to the Issuer has not been terminated as defined under the Plan. The option expires ten years after the date of grant.